Kristin Wynholds's most recent trade in Better Therapeutics Inc was a trade of 25,362 Common Stock done . Disclosure was reported to the exchange on Dec. 18, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Better Therapeutics Inc | Kristin Wynholds | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2023 | 25,362 | 225,631 | - | 0 | Common Stock | |
| Better Therapeutics Inc | Kristin Wynholds | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 101,450 | 101,450 | - | - | Stock Option (Right to Buy) | |
| Better Therapeutics Inc | Kristin Wynholds | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 101,450 | 200,269 | - | 0 | Common Stock | |
| Better Therapeutics Inc | Kristin Wynholds | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 1.54 per share. | 31 May 2022 | 5,023 | 95,038 | - | 1.5 | 7,728 | Common Stock |
| Better Therapeutics Inc | Kristin Wynholds | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 1.24 per share. | 31 May 2022 | 3,781 | 98,819 | - | 1.2 | 4,692 | Common Stock |
| Better Therapeutics Inc | Kristin Wynholds | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 116,700 | 116,700 | - | - | Stock Option (Right to Buy) |